spacer
home > ict > Spring 2006
PUBLICATIONS

International Clinical Trials

ict
Spring 2006
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT
   
Text
PDF
Pam Barnacal introduces the inaugural ICT in her Editor’s Letter

 
download pdf
bullet
TRIAL MANAGEMENT
Emma-Kate Yates at Fast4Wd Ogilvy addresses the thorny issue of recruitment and enrolment for clinical trials in oncology, in Patients Are a Virtue  
download pdf
Taking the UK as their case study, Diana Anderson and Beth Harper at D Anderson & Company demystify the regulations involved in patient recruitment, in Going Through Customs  
download pdf
In A CRO’s Progress, ICT talks to Nigel Page, President of i3 Research, about how a business with therapeutic specialisation in mind can stay on top in a tough market  
download pdf
bullet
eCLINICAL
With ever-spiralling costs relating to the development of drug candidates,Valarie Higgins, Ellen Shea and Eva R Miller at Biostatistics, affiliated with Interactive Clinical Technologies, Inc, see promise in Intelligent Design  
download pdf
Electronic data collection, though by no means a new technology, is now beginning to demonstrate its full potential. Khaled El Emam, Chief Scientist at TrialStat Corporation, maps out this Industrial Evolution  
download pdf
Since electronic data capture systems noticeably speed up clinical data collection, David Fishbach at Phase Forward is moved to ask, Does EDC Herald the End of CTMS?  
download pdf
Mark Wheeldon at Formedix Ltd argues that EDC requires a vendor-neutral, platform-independent utility, in his article on CDISC: Eliminating Standard Deviation  
download pdf
bullet
IT & LOGISTICS
In Reading the Signals, Judy Hanover and Alison Hodges at Lincoln Technologies consider the various strategies devised to combat safety concerns in the industry – concentrating on the twin elements of signal detection and data mining  
download pdf
A high-performing supply chain is currently an industry hot topic, since it is critical in accelerating clinical development. Kunal Khattar at InfoPro Solutions, Inc, reports on Supply In Demand  
download pdf
bullet
CLINICAL THERAPEUTICS
In Curing Cancer: A New Technique Makes its Mark, Dr Lee Schacter at MDS Pharma Services talks about intelligent anticancer treatment, and its fast-growing status as the most promising method of tackling this destructive disease  
download pdf
The beauty of industry-conducted patient registries are that they benefit the public and the industry. Jean Siebenaler at Kendle shows us the Best of Both Worlds  
download pdf
bullet
MARKETPLACE
As a region at various stages of industrialisation and development, Latin America shows some promise. Dr Faiz Kermani of Chiltern International explains Clinical Research – Latino Style, showing how the pharmaceutical industry can help to drive overall improvements in the area  
download pdf
For the pharmaceutical industry, complying with European regulations can cause Legal Landmines and Operational Headaches. Arianna Greco and Fabio Marazzi of M+BIOLAW offer some pain relief  
download pdf
With widespread adoption of the electronic Common Technical Document imminent, Jim Nichols at Thomson Scientific, Liquent Regulatory Solutions Division, previews the advantages it will offer, in eCTD: No Longer Submission Impossible  
download pdf
bullet
PREVIEW
Now in its 42nd year, the DIA Annual Meeting Update offers, as always, an unmissable symposium for global pharma  
download pdf
bullet
INFORMATION
 
 
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

High throughput, low energy consumption: AVENTUS to showcase high-performance packaging systems at interpack

Joint venture for a broad range of solutions Powerful and low-maintenance units for free-flowing bulk materials Solutions for agriculture as well as the chemicals, salts, fertilisers pet food and animal feed industries
More info >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement